Login / Signup

Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).

William H PolonskyRiya AroraMads FaurbyJoão FernandesAndreas Liebl
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
In US clinical practice, once-weekly injectable treatments are associated with better persistence and adherence than daily regimens over 1 year. Once-weekly regimens may also benefit patients with more advanced T2D.
Keyphrases
  • clinical practice
  • physical activity
  • hyaluronic acid
  • glycemic control
  • metabolic syndrome
  • skeletal muscle
  • adipose tissue